AKR.L Share News (AKR)

AKR.L Information

There is currently no data for AKR

Akers Narrows Nine Month Pretax Losses As Revenues Rise

Fri, 15th Nov 2013 14:55

LONDON (Alliance News) - Akers Biosciences Inc. Friday reported a narrowed pretax loss as revenues rose in the nine months ended September 30.

The biotechnology company is moving to the NASDAQ, and subsequently provided its results under US accounts standards.

Akers posted a pretax loss of USD745,125, narrowed from a pretax loss of USD1.9 million in the previous year. Revenues rose to USD3.0 million from USD1.2 million.

Some of the rises in revenues was offset by sale costs rising to USD1.5 million from USD691,628 in the previous year.

Shares in Akers were trading down 1.2% at 3.90 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

More News

6 Oct 2015 08:03

Akers Biosciences To Launch Two New Health Breath Tests

30 Sep 2015 09:13

Akers Biosciences Signs Four More Distribution Deals

14 Sep 2015 15:30

Akers Biosciences launches ketosis fat-burning breath test via Amazon

(ShareCast News) - Akers Biosciences has begun to make direct sales of its disposable breath ketone test, Metron, through the Amazon website and via the company's online sales portal. The medical device company said the Metron Breath Ketone Test, which is part of its health and wellness line, is the

14 Sep 2015 07:07

Akers Bioscience Launches Disposable Breath Ketone Test Metron

18 Aug 2015 11:28

Akers Biosciences plummets as interim loss widens

(ShareCast News) - Akers Biosciences plummeted after the medical device company said its pre-tax loss widened in the first half as revenue declined. Akers posted a pre-tax loss of $3.41m for the six months ended 30 June, wider than the $1.1m loss in the same period last year. This included a one-tim

18 Aug 2015 11:08